REGEN BIOPHARMA, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $906.3K | $319.4K | $24.8K |
| FY2017 | $6.2M | $944.2K | $270.0K |
| FY2018 | $9.3M | $209.0K | $8.0K |
| FY2019 | $11.0M | $99.1K | $7.9K |
| FY2020 | $7.5M | $123.2K | $0 |
| FY2021 | $14.7M | $1.2M | $727.2K |
| FY2022 | $8.6M | $559.0K | $51.2K |
| FY2023 | $5.5M | $353.6K | $121.0K |
| FY2024 | $5.4M | $161.1K | $716 |
| FY2025 | $6.6M | $274.6K | $69.6K |